Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.19%
1,066.21
-2.03
-0.19%
1,068.241,067.921,077.071,063.77
SIXC
Communications
SIXC
Communications
SIXC
+0.75%
611.16
+4.57
+0.75%
606.59606.59615.68605.82
SIXE
Energy
SIXE
Energy
SIXE
+1.82%
1,269.93
+22.72
+1.82%
1,247.211,244.281,272.821,231.77
SIXI
Industrials
SIXI
Industrials
SIXI
-0.42%
1,720.41
-7.17
-0.42%
1,727.581,727.121,727.751,708.63
SIXM
Financials
SIXM
Financials
SIXM
+1.21%
637.13
+7.59
+1.21%
629.54628.87637.90628.46
SIXR
Staples
SIXR
Staples
SIXR
+1.48%
866.25
+12.65
+1.48%
853.60854.40866.55854.06
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.23%
214.64
+2.60
+1.23%
212.04212.04214.86212.04
SIXT
Technology
SIXT
Technology
SIXT
-1.09%
3,511.13
-38.63
-1.09%
3,549.763,571.063,579.253,461.89
SIXU
Utilities
SIXU
Utilities
SIXU
+0.05%
886.92
+0.43
+0.05%
886.49888.59891.95878.92
SIXV
Health care
SIXV
Health care
SIXV
+0.42%
1,470.49
+6.15
+0.42%
1,464.341,460.441,471.431,455.16
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.19%
2,349.77
-4.48
-0.19%
2,354.252,352.682,379.542,334.76
ABOS:NASDAQ
Acumen Pharmaceuticals Inc
$2.18
-4.39%
(-0.100) 1D
$2.16
-0.92% (-0.020)
Pre-market
Closed: May 18, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ABOS...
Open
$2.28
High
$2.30
Low
$2.14
Mkt. cap
157.46M
Avg. vol.
342.33K
Volume
0.00
52-wk high
$3.60
52-wk low
$0.99
EPS
-$1.86
Beta
0.32
Shares outstanding
72.23M
No. of employees
60
News stories
From sources across the web
About Acumen Pharmaceuticals Inc
CEO-
Employees60
FoundedJan 1, 1996
HeadquartersNewton, Massachusetts, United States
SectorBiotechnology
Last report
May 12, 2026
Fiscal Period
Q1 2026
EPS / Est. (USD)
-$0.33 / -$0.46
+28.26%beat
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
37.12M
21.97M
20.53M
-
Cost of revenue
37.12M
21.97M
20.53M
-
Research and development expenses
-
-
-
16.48M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.62M
4.54M
4.67M
4.66M
Operating expense
4.62M
4.54M
4.67M
21.15M
Total operating expenses
41.75M
26.51M
25.20M
21.15M
Operating income
-41.75M
-26.51M
-25.20M
-21.15M
Other non operating income
-169.00K
-509.00K
-174.00K
417.00K
EBT including unusual items
-40.95M
-26.45M
-25.14M
-20.74M
EBT excluding unusual items
-40.95M
-26.45M
-25.14M
-20.74M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-40.95M
-26.45M
-25.14M
-20.74M
Net profit margin
-
-
-
-
Earnings per share
-0.68
-0.44
-0.41
-0.33
Interest and investment income
2.02M
1.64M
1.32M
1.06M
Interest expense
-1.05M
-1.07M
-1.09M
-1.07M
Net interest expenses
969.00K
571.00K
235.00K
-5.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-41.73M
-26.50M
-25.19M
-21.14M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more